Year: 2017
Type: review
Abstract: Diabetes remains one of the leading causes of morbidity and mortality worldwide, affecting an estimated 422 million adults. In the US, it is predicted that one in every three children born as of 2000 will suffer from diabetes in their lifetime. Type 2 diabetes results from combinatorial defects in pancreatic β-cell glucose-stimulated insulin secretion and in peripheral glucose uptake. Both processes, insulin secretion and glucose uptake, are mediated by exocytosis proteins, SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complexes, Sec1/Munc18 (SM), and double C2-domain protein B (DOC2B). Increasing evidence links deficiencies in these exocytosis proteins to diabetes in rodents and humans. Given this, emerging studies aimed at restoring and/or enhancing cellular levels of certain exocytosis proteins point to promising outcomes in maintaining functional β-cell mass and enhancing insulin sensitivity. In doing so, new evidence also shows that enhancing exocytosis protein levels may promote health span and longevity and may also harbor anti-cancer and anti-Alzheimer’s disease capabilities. Herein, we present a comprehensive review of the described capabilities of certain exocytosis proteins and how these might be targeted for improving metabolic dysregulation.
Authors: Arianne Aslamy, Debbie C. Thurmond
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: bronze
Awards: G1218922180, Indiana Clinical and Translational Sciences Institute, Targeting an atypical signaling hub to restore and protect whole body glucose homeostasis, G3276486592, G5767090434, Regulating SNARE mechanisms to remediate glucose homeostasis, G862771650, Regulating SNARE mechanisms to remediate glucose dyshomeostasis, G988482584
OpenAlex ID: W2601995026
